|Year : 2018 | Volume
| Issue : 2 | Page : 181-187
Antiurolithic and antioxidant activity of ethanol extract of whole-plant Biophytum sensitivum (Linn.) DC in Ethylene-Glycol-induced urolithiasis in rats
BR Abhirama1, R ShanmugaSundaram2
1 Department of Pharmaceutical Chemistry, JKK Nattraja College of Pharmacy, Kumarapalayam, Tamil Nadu, India
2 Department of Pharmacology, JKK Nattraja College of Pharmacy, Kumarapalayam, Tamil Nadu, India
|Date of Web Publication||20-Apr-2018|
Dr. B R Abhirama
Department of Pharmaceutical Chemistry, JKK Nattraja College of Pharmacy, NH-544, Salem-Coimbatore Highways, Natarajapuram, Kumarapalayam, Tamil Nadu
Source of Support: None, Conflict of Interest: None
| Abstract|| |
Background: Biophytum sensitivum Linn. DC is considered as one of the ten sacred plants called as “Dasapushpam” of Kerala state in India. Grounded leaves of this plant have been used conventionally as antiurolithic and diuretic. 'However, enough scientific evidences were not available about the effect of this plant as nephroprotective and antiurolithic. Objective: The present study was undertaken to investigate antiurolithic and antioxidant activity of ethanol extract of whole plant B. sensitivum Linn. DC (EEBS) on ethylene-glycol (EG)-induced urolithiasis in Wistar albino rats. Materials and Methods: EG 0.75% v/v in drinking water was fed to all groups, except the control group for 28 days to induce urolithiasis in rats. Groups I, II, and III served as control, toxic control, and standard Cystone groups, respectively. Animals in Group IV were administered with EEBS from 15th day to 28th day, while Group V animals were administered with EEBS from 1st day to 28th day. Several renal functional and injury markers in urine and serum were determined. Antioxidant enzyme activities were also recorded. Results: Co-administration with EEBS exhibited protective effect against EG-induced proteinuria, hypercalciuria, hypomagnesuria hypercalcemia, and hyperphosphatemia. Serum protein levels were significantly increased, whereas blood urea nitrogen, creatinine, and uric acid levels were significantly lowered. EEBS-treated rats significantly attenuated the aberrations in the antioxidant enzyme activities, body weight, kidney weight, urine output, and urine pH compared to toxic control animals. Conclusion: Hence, this study confirmed the usefulness of B. sensitivum as an antiurolithic and antioxidant agent.
Abbreviations Used: EEBS: Ethanol extract of Biophytum sensitivum, EG: Ethylene-glycol, B.wt: Body weight, TP: Total protein, Ca: Calcium, Mg: Magnesium, BUN: Blood urea nitrogen, K.wt: Kidney weight, SOD: Superoxide dismutase, GPx: Glutathione peroxidase, GSH: Reduced glutathione, MDA: Malondialdehyde.
Keywords: Antioxidant, antiurolithic, Biophytum sensitivum, Cystone, ethylene-glycol
|How to cite this article:|
Abhirama B R, ShanmugaSundaram R. Antiurolithic and antioxidant activity of ethanol extract of whole-plant Biophytum sensitivum (Linn.) DC in Ethylene-Glycol-induced urolithiasis in rats. Phcog Res 2018;10:181-7
|How to cite this URL:|
Abhirama B R, ShanmugaSundaram R. Antiurolithic and antioxidant activity of ethanol extract of whole-plant Biophytum sensitivum (Linn.) DC in Ethylene-Glycol-induced urolithiasis in rats. Phcog Res [serial online] 2018 [cited 2020 Feb 25];10:181-7. Available from: http://www.phcogres.com/text.asp?2018/10/2/181/230757
Antiurolithic and antioxidant activity of ethanol extract of whole-plant B. sensitivum Linn. DC (EEBS) on ethylene-glycol-induced urolithiasis in Wistar albino rats were evaluated. Phytochemical screening indicated the presence of carbohydrates, alkaloids, steroids, saponins, proteins, aminoacids, flavonoids, fixed oils, tannins, and phenolic compounds. Based on the reports of previous research work, it can be confirmed that flavonoids and saponins present in this plant might be responsible for its nephroprotective and antiurolithic activities.
| Introduction|| |
Urolithiasis is a worldwide problem and is estimated that 12% of the world population experiences renal stone disease with a recurrence rate of 70%–80% in male and 47%–60% in female. Kidney stone formation is the third most common affliction of the urinary tract, which is exceeded by the urinary tract infections and prostate diseases. At present, no satisfactory drugs are available in the market for the treatment, prevention, or recurrence of kidney stone formation. Synthetic drug for the treatment of urolithiasis is associated with higher incidence of adverse drug reactions. Invasive procedures including extracorporeal shock wave lithotripsy, ureteroscopy, and nephrolithotomy are considered to be effective, but they are costly, may reduce renal functions, and cause acute renal injury, infections, and recurrence of kidney stone formation.
As various etiological factors are involved in stone formation, the treatment is aimed at multiple targets such as antispasmodic, anti-inflammatory, diuretics, antibiotics, muscle relaxants, analgesics, and antioxidant activities. Preclinical studies have demonstrated that calcium oxalate crystals directly induce renal epithelial cell injury mediated through lipid peroxidation (LPO) and oxygen-free radical generation. Recent clinical data are also supporting such findings that formation of urinary stones leads to oxidative stress in patients. Multiple chemical constituents present in medicinal plants aimed at multiple targets and may offer effective, inexpensive, and safe remedy for the treatment of urolithiasis. Ureteric calculus disappeared within 55 days of treatment with “Cystone” a herbomineral composition, by inducing diuresis.
Biophytum sensitivum Linn. DC (common names: Nilaccurunki, Tintaanaalee in Tamil; Mukkutti in Malayalam; Lajalu, Lajjaalu, Lakshmana in Hindi) belongs to family Oxalidaceae. Phytochemical investigation of B. sensitivum had revealed the presence of large amount of phenolic and polyphenolic compounds, saponins, polysaccharides, pectin, and essential oils. Main bioactive constituents are bioflavonoids such as amentoflavone with trace amounts of cupressoflavone, luteolin, isoorientin, and isovitexin., Whole-plant B. sensitivum has been used conventionally in the treatment of urinary calculi. Recent pharmacological studies showed that it has antioxidant, antibacterial, antidiabetic, antitumor,, cardioprotective, immunomodulation, radioprotective, anti-inflammatory activites and many more. The search for antilithiatic drugs possessing significant antioxidant activities from natural sources has gained great potential, and therefore, the present study was aimed to investigatein vivo antiurolithic and antioxidant activity of ethanol extract of whole-plant B. sensitivum (EEBS) on ethylene-glycol (EG)-induced urolithiasis in Wistar albino rats.
| Materials and Methods|| |
Adult male albino rats of Wistar strain weighing between 150 and 200 g were housed in clean polypropylene cages with stainless steel filter tops under the standard laboratory condition of 12:12 dark and light cycle, 50% humidity, and temperature 25°C ± 2°C. They were allowed free access to standard commercial rat feed pellets (SAI Animal Feed Ltd., Bangalore, India) and were given water ad libitum. The animals were acclimatized to the laboratory condition for 7 days before the commencement of experiments. The experiments were performed based on Animal Ethics Guidelines of Institutional Animals Ethics Committee (KMCRET/Ph. D/12/2015-16). The rats received human care according to the guidelines of Committee for the Purpose of Control and Supervision of Experiments on Animals.
Drugs and chemicals
EG was obtained from Qualigens Fine Chemicals, Mumbai, India, and Cystone was procured from Himalaya Health Care, Bangalore, India. All other chemicals and reagents used in this study were of analytical grade.
EG-induced urolithiasis model was used to assess the antiurolithic and antioxidant activity in Wistar albino rats., Animals were divided into five groups, containing six animals each, designated as Groups I, II, III, IV, and V. Group I served as normal control and received regular rat food and drinking water ad libitum. EG (0.75% v/v) in drinking water was fed to Group II to Group V for the induction of renal calculi, for a period of 28 days. Group II served as lithiatic control and received vehicle (1% tween 80). Group III received standard antiurolithic drug, Cystone (750 mg/kg p.o.) from 15th day to 28th day. Group IV served as curative regimen received EEBS (250 mg/kg) from 15th day to 28th day. Group V received EEBS (500 mg/kg) from 1st day to 28th day, served as preventive regimen. Extracts were given once daily p.o.
Plant source and identification
The whole-plant B. sensitivum was collected from Shevaroy Hills, Salem District, Tamil Nadu, and was taxonomically identified and authenticated by Dr. A. Balasubramanian, Executive Director, ABS Botanical Conservation, Research and Training Centre, Karipatti, Salem (Dt.), Tamil Nadu (Ref. No-AUT/JKK/095).
Preparation of plant extract
The whole plant was washed and dried in shade for about 3 weeks. Dried plant was coarsely powdered, sieved (mesh size = 40), and stored in an air-tight container at room temperature. Powdered plant material (500 g) was sequentially extracted with petroleum ether (60°C–80°C) for defatting the drug and then with 70% ethanol using soxhlation method. The obtained solvent extract was filtered and evaporated to dryness at 45°C under reduced pressure using a rotary evaporator. The dried extract was stored in the air-tight container.
The EEBS was tested for the presence of alkaloids, flavonoids, phenolic compounds, tannins, glycosides, proteins, saponins, terpenoids, steroids, carbohydrates and starch using the standard procedures.
Acute toxicity studies
Acute oral toxicity studies were not performed as studies of ethanolic extracet of whole plant B.sensitivum have already been reported. Previous studies by Anidya et al., used 5000 mg/kg dose of EEBS in albino rats. Hence, one-tenth of this dose, 500 mg/kg, and lower dose 250 mg/kg have been selected for the present study.
Analysis of urine
At the end of treatment, the animals were housed in individual metabolic cages and 24-h urine samples were collected on the 28th day. Change in body weight, water intake, urine volume, and pH were recorded after completing the experimental period. Total urine volume was measured using the measuring cylinder and reported in mL. The acidity of the urine was tested using a pH meter. A drop of concentrated HCl was added to the collected urine and stored at 4°C. Urine was then analyzed for total protein, calcium, phosphate, and magnesium.
Analysis of blood
After collecting the urine, animals were then anesthetized with ketamine hydrochloride and the blood was collected from tail vein under mild anesthetic condition. Serum was separated by centrifugation at 10,000 rpm for 20 min and analyzed for total protein, calcium, magnesium, phosphate, blood urea nitrogen (BUN), uric acid, and creatinine.
Kidney homogenate analysis
The rats were sacrificed after the administration of last dose of toxicant by euthanasia method. Both kidneys from each animal were isolated, washed, with ice-cold physiological solution. The left kidney was homogenized with a motor-driven Teflon-coated homogenizer with 0.1 M Tris-HCl buffer (pH 7.4) to get 10% w/v homogenate. The homogenate was then centrifuged for 10,000 rpm at 4°C for 10 min. The clear supernatant was collected and used for the estimation of superoxide dismutase (SOD), catalase, glutathione peroxidase (GPx), reduced glutathione (GSH), and malondialdehyde (MDA) levels.
Determination of total protein content
Total protein content was determined by the method of Lowry et al. 4.5 mL of alkaline (6 mmol/L) CUSO4 reagent and 0.5 mL of Folin's phenol reagent were added to test tubes containing working standard (bovine serum albumin, 100 mg/mL); 0.2 mL of test solution. Distilled water of 1 mL served as blank. Mixed well and the blue color developed was observed at 640 nm after 15 min.
Determination of calcium level
The estimation was followed by the instructions according to the Clinichem calcium kit manufacturer, based on the method of Lorentz. 1 mL working reagent was added to test tubes containing 20 μL standard solution, 20 μL sample used as test solution, and 20 μL distilled water used as blank. Mixed and incubated the reaction mixtures at room temperature for 5 min, and the absorbance was measured at 570 nm.
Determination of phosphate level
Phosphate level was determined by the method of Fiske and Subbarow. 1 mL of 2.5% molybdic acid reagent was mixed with 5 mL protein-free filtrate/urine and 5 mL standard solution. Mixed all the solutions well and added 0.4 mL of 0.25% amino naphtha sulfonic acid and made up to 10 mL mark with distilled water. Kept for 5 min, and the absorbance was measured at 680 nm.
Determination of magnesium level
Urinary and serum levels of magnesium were determined according to the method of Heaton. 1 mL serum/urine was mixed with 6 mL trichloroacetic acid (10%). The tubes were shaken, allowed to stand for at least 10 min, and centrifuged. 2 mL of supernatant was then mixed with 0.5 mL polyvinyl alcohol (0.2%), 2.5 mL titan yellow (15 mg%), and 1 mL sodium hydroxide (20%) and allowed to stand for 10–20 min. For standard, 1 mL magnesium sulphate solution was used. 1 mL distilled water was used as blank. The absorbance was measured at 540 nm.
Determination of blood urea nitrogen level
The BUN was estimated by Berthelot method (Fawcett and Scott) using the commercially available kit (Kamineni Life Sciences Pvt. Ltd. Hyderabad, India). 1000 μL of working reagent-I containing urease reagent and a mixture of salicylate, hypochlorite, and nitroprusside were added to 10 μL of serum, 10 μL of standard urea (40 mg/dL), and 10 mL of purified water to prepare test, standard, and blank, respectively. Mixed well and incubated at 37°C for 5 min. Then, 1000 μL of reagent-II containing alkaline buffer was added to all the test tubes, which were incubated at 37°C for 5 min. The intensity of blue-green color produced is directly proportional to the concentration of urea in the sample and absorbance was measured spectrophotometrically at 578 nm.
Determination of uric acid level
Uric acid content was estimated by following the method of Caraway. To 2 mL of supernatant of serum after centrifugation or standard uric acid solution were mixed with 0.6 mL of 10% phosphotungstic acid and 0.6 mL of 10% sodium carbonate. A blank was set up with 3.0 mL of water. After 10 min, the color developed was read at 640 nm.
Determination of creatinine level
The serum creatinine concentration was estimated using the commercially available kit (Cresent Biosystems, Goa, India) by alkaline picrate method (Bonsnes and Taussky). 2.0 mL of picric acid reagent was added to 0.2 mL of serum, mixed well, and centrifuged at 3000 rpm to obtain a clear supernatant. 100 μL of buffer reagent was added to 1.1 mL of supernatant, 0.1 mL of standard creatinine, and 0.1 mL of distilled water to prepare test, standard, and blank, respectively. 1.0 mL of picric acid reagent was added to blank and standard. The intensity of orange color formed was read at 520 nm spectrophotometrically.
Determination of superoxide dismutase
SOD was estimated according to the procedure described by Kakkar et al. 0] 0.5 mL of kidney homogenate was diluted with distilled water (0.5 mL) and treated with 0.25 mL of ethanol and 0.15 mL of chloroform. Supernatant of kidney homogenate was removed after centrifuging the mixture for 1 min. 1.5 mL of buffer was added to 0.5 mL of kidney homogenate and the reaction was started by adding 0.4 mL of epinephrine. Change in optical density per minute was determined at 480 nm in double beam UV-VIS spectrophotometer. Activity of SOD was expressed as unit/min/mg of protein.
Determination of catalase
The catalase activity was assayed by the method of Sinha. Kidney homogenate (0.1 mL) was mixed with 1.0 mL of phosphate buffer and 0.5 mL of hydrogen peroxide. 1 mL of the reaction mixture was withdrawn and 0.2 mL dichromate/acetic acid reagent was blown at the interval of 1 minute to arrest the reaction. The standard hydrogen peroxide in the range of 4 to 20 μL were taken and treated similarly. The tubes were heated in a boiling water bath for 10 min. The green color developed was read at 570 nm and the activity of catalase was expressed as μmol of hydrogen peroxide consumed/min/mg protein.
Determination of glutathione peroxidase
The glutathione peroxidase activity was measured according to the method of Rotruck et al. 0.2 mL each of EDTA, sodium azide, reduced glutathione, hydrogen peroxide, 0.4 mL of buffer and 0.1 mL of enzyme (kidney homogenate) were mixed and incubated at 37°C for 10 min. The reaction was arrested by the addition of 0.5 mL of tricarboxylic acid and the tubes were centrifuged. To 0.5 mL of supernatant, 3mL of sodium hydrogen phosphate and 1 mL of 5,5′-dithiobis(2-nitrobenzoic acid) were added and the color developed was read at 412 nm. GPx activity is expressed as μ moles of glutathione oxidized/min/mg protein.
Determination of reduced glutathione
Reduced glutathione was estimated by Ellman's procedure. Tissue homogenate (250 mL) was treated with 1 mL of 5% tricarboxylic acid in a 2 mL Eppendorf tube and precipitate was removed by centrifugation at 3000 rpm for 10 min at room temperature. To 250 mL of the above supernatant, 1.5 mL of 0.2 M phosphate buffer was added and mixed well. 250 mL of 0.6 mM of Ellman's reagent [5,5′-Dithiobis(2-nitrobenzoic acid) solution] was added to the above mixture and the absorbance was measured at 412 nm within 10 min. Amount of glutathione expressed as μg/mg of protein.
Determination of lipid peroxidation
LPO was estimated by the method of Okhawa et al. 1 mL of kidney homogenate was mixed with 0.2 mL 4% (w/v) sodium dodecyl sulfate, 1.5 mL 20% acetic acid in 0.27 M hydrochloric acid (pH 3.5), and 15 mL of 0.8% thiobarbituric acid (TBA, pH 7.4). The mixture was heated in a hot water bath at 85°C for 1 h. The intensity of the pink color developed was read against a reagent blank at 532 nm. The concentration was expressed as n moles of MDA per mg of protein.
The right kidney was fixed in 10% neutral-buffered formalin, processed in a series of graded alcohol and xylene, embedded in paraffin wax, sectioned at 5 μm, and stained with hematoxylin and eosin for histopathological examination.
The results were expressed as mean ± SEM. Statistical significance between means was analyzed by one-way analysis of variance followed by “Dunnett's test.” P < 0.05 was considered statistically significant.
| Results|| |
The percentage yield of petroleum ether extract of B. sensitivum and EEBS was 4.92% w/w and 12.54% w/w, respectively. Preliminary phytochemical investigation indicated that EEBS showed the presence of carbohydrates, steroids, flavonoids, alkaloids, fixed oils, tannins, saponins, protein, aminoacid and phenolic compounds.
Effect of ethanol extract of Biophytum sensitivum on general and urinary parameters of control and experimental animals
[Table 1] depicts the effect of EEBS on general and urinary parameters of control and experimental animals that were obtained at the end of the experiment in each group. Body weight was measured before starting the experiment. Parameters recorded on the 28th day during the experimental period revealed that there was significant (P< 0.001) gain in body weight in animals co-treated with 250 mg/kg and 500 mg/kg of EEBS and Cystone (750 mg/kg) compared to calculi-induced group [Table 1], Groups III, IV, and V]. Significant (P< 0.001) weight reduction was observed in Group II animals compared to control group [Table 1], Group II]. Similarly, urine volume was significantly (P< 0.01) higher in Cystone and both EEBS-treated groups [Table 1], Group III, IV, V], compared to animals in Group II. Changes in urine pH with respect to the doses were found to be significant (250 mg/kg: 7.1 ± 0.05 and 500 mg/kg: 6.9 ± 0.10). The urine pH was reduced significantly (P< 0.01) in extract and Cystone-treated rats compared with animals in Group II. In this study, total protein, calcium, and phosphate content in urine increased significantly (P< 0.001) in EG-induced group compared to control, whereas p.o. administration of 250 and 500 mg/kg of EEBS attenuated total protein and calcium levels (p<0.01). Total protein (p<0.001), calcium and phosphate levels (p<0.01) were significantly lowered in animals co-treated with Cystone. Magnesium excretion was significantly (P< 0.05) reduced in EG-treated group compared to control group. Treatment with Cystone at the dose of 750 mg/kg (P< 0.01) and EEBS 500 mg/kg (P< 0.001) significantly increased magnesium level compared to lithiatic group [Table 1], Groups III, V].
|Table 1: Effect of EEBS on general and urinary parameters of control and experimental animals|
Click here to view
Effect of ethanol extract of Biophytum sensitivum on serum biochemistry of control and experimental animals
[Table 2] illustrates the effect of EEBS on serum parameters of control and experimental animals in each group. The serum levels of calcium, phosphate, creatinine, uric acid (P < 0.01), BUN (P < 0.001), and magnesium (P< 0.05) were significantly elevated, whereas total protein levels (P < 0.001) were lowered in calculi-induced animals compared to control group, indicating impaired renal function [Table 2], Group II]. Co-treatment with Cystone ( P<0.01) and EEBS at 250 mg/kg (curative regimen) and 500 mg/kg (preventive regimen) significantly (P< 0.001) increased serum total protein, whereas BUN, creatinine, uric acid, calcium, and phosphate levels were were significantly reduced, compared to calculi-induced group [Table 2], Groups III, IV, V].
|Table 2: Effect of EEBS on serum biochemistry of control and experimental animals|
Click here to view
Effect of ethanol extract of Biophytum sensitivum on markers of oxidation in control and experimental animals
The effect of EEBS on LPO and antioxidant status in rats exposed to EG-induced urolithiasis showed a significant (P< 0.01) decrease in SOD, CAT, GSH, and GPx level compared to Group I normal animals [Table 3], Group II]. Compared to animals in group II, co-administration of EEBS significantly increased GPx and SOD levels. A significant (P< 0.01) increase in production of MDA was observed in Group II toxic control animals compared to Group I normal animals. Co-administration of Cystone EEBS to Group IV and Group V animals significantly (P< 0.01) decreased MDA levels compared to Group II animals [Table 3] (Groups III, IV, V).
|Table 3: Effect of EEBS on markers of oxidation in control and experimental animals|
Click here to view
Results of histopathological studies
Histopathological analysis revealed severe glomeruli injury and hematuria indicated by RBCs deposition, interstitial inflammation, and dilation of proximal tubules along with crystal deposits, in calculi-induced rats [Figure 1]c and [Figure 1]d. There were no abnormalities or calcium oxalate deposits inside tubules of animals in normal control group [Figure 1]a and [Figure 1]b. Group IV animals treated with EEBS at a dose of 250 mg /kg showed normal glomerulus, tubular dilation with crystal deposits, normal tubular vacuolation and epitelial loss. [Fiure 1e and f]. Co-administration with EEBS at a dose of 500 mg/kg in Group V animals [Figure 1]i and [Figure 1]j markedly decreased crystal deposition in renal tubules compared to animals treated with EG in group II.
|Figure 1: Light microscopic histology and calcium oxalate deposits in the section of kidney. Left side showing kidney section of glomerular region and right side showing tubular region. (a and b) Normal control rat. (c and d) Ethylene-glycol-induced urolithiasis rat. (e and f) Cystone-treated rat. (g and h) Ethanol extract of Biophytum sensitivum (250 mg/kg)-treated rat. (i and j) Ethanol extract of Biophytum sensitivum (500 mg/kg)-treated rat (40× for all images)|
Click here to view
| Discussion|| |
Agents such as EG, sodium oxalate, ammonium oxalate, and glycolic acid are commonly used for inducing urolithiasis. In this study, EG was used to induce renal stone formation in male rats. Urinary system of male rats resembles that of human  andin vivo accumulation of glycolic acid, a metabolite of EG in the body is responsible for nephrotoxicity.
A significant decrease in body weight and water intake was observed in calculi-induced group compared to animals in control group. Decreased in the quantity and frequency of food intake was found to be the major factor of weight loss. Physiological imbalance and/or mental stress may be the other factors influencing weight reduction. Administration of EEBS results in increased intake of diet (frequency and quantity), water intake, and subsequent increase in body weight. Decreased urine output plays a major role in inducing kidney stones. Both curative and preventive doses of EEBS increased urine output in a dose-dependent manner along with normalization of pH. These results indicated that the diuretic activity of EEBS promotes flushing out of deposits, thereby inhibiting saturation and precipitation of stone forming constituents. Nucleation and aggregation of crystals in urine is pH dependent. Uric acid stones are predominant in highly acidic urine, whereas calcium oxalate and calcium phosphate stones occur in highly alkaline urine., In this study, pH of urine was found to be 8.2 ± 0.11 in calculi-induced animals in Group II, indicating a favorable environment for the formation of kidney stones. Treatment with plant extracts (EEBS 500 mg/kg) significantly reduced urine pH to 6.9 ± 0.10. In response to 28 days of EG (0.75% v/v) treatment, the risk of formation of renal calculi increased by raising the level of stone forming constituents in urine. Excess level of stone forming chemicals in the urine results in toxic effects on the renal epithelial cells, leading to alteration in membrane integrity, generation of reactive oxygen species, development of oxidative stress, and depleted source of antioxidant enzymes and LPO. Renal epithelial injury further promotes retention as epithelial injury exposed to a variety of crystal adhesion molecules. Increased concentration of urinary calcium is a factor favoring the nucleation, aggregation, or retention of calcium oxalate or calcium phosphate. Promising results in preventing recurrence have been shown in patients treated with potassium magnesium citrate. Magnesium deficiency promotes the nucleation and retention of calcium in renal tubule. Magnesium binds to oxalate to form a soluble complex and reduces the concentration available for calcium oxalate precipitation. Increased urinary excretion of protein reflects proximal tubular dysfunction. Increased urinary excretion of calcium and phosphate observed in calculi-induced group (Group II) provides an environment appropriate for calcium phosphate crystals formation. Supplementation with EEBS (500 mg/kg) served as a preventive regimen and the curative regimen receiving EEBS at a dose of 250 mg/kg significantly restored the alteration in the level of urinary calcium. Total protein level was significantly reduced and magnesium level was increased in animal group treated with EEBS, which clearly indicating antiurolithic activity of EEBS.
Glomerular filtration rate decreases due to the obstruction to the outflow of urine by stones in the urinary system or due to the damage of renal parenchyma. This promotes accumulation of the waste products, particularly nitrogenous substances such as urea, creatinine, and uric acid in the blood. This study showed a significant increase in serum uric acid, creatinine, BUN, calcium, magnesium, and phosphate level in the EG-treated group compared to normal control. These serum biochemicals except magnesium decreased following treatment with EEBS in dose-dependent manner. Serum total protein level was found to be elevated in Group III, Group IV, and Group V animals, indicating inhibition of urolithiasis.
Oxidative stress is a condition associated with reduction in endogenous antioxidative enzyme level, which catalyze neutralization of many types of free radicals. These enzymes play a significant role in destroying the peroxides and promote antioxidant defenses to an organism. Lowering of their activities resulted in the accumulation of lipid peroxides and increased oxidative stress. In this study, it was observed that EEBS treatment, serving both as preventive and curative regimens, significantly decreased MDA levels and increased activity of antioxidant enzymes in the kidneys, thereby inhibiting the changes associated with oxidative stress.
Histopathological examination of the kidneys substantiated the results obtained fromin vivo evaluation of antiurolithic and antioxidant activity in animals. Dilation of renal tubule, hematuria, and glomerular injury might be due to the presence of crystals which causes obstruction in tubular blood flow. Kidney weight was significantly increased in calculi-induced group (P< 0.001) compared to normal control group. Significant weight reduction of the kidney was observed in animals treated with EEBS which might be due to the increased excretion of stone-forming chemicals. Previous studies have confirmed and reported that 28 days of EG (0.75%, v/v) administration in rats resulted in the formation of renal calculi. Recent clinical data also suggested the use of extract of various plants as antioxidant and antiurolithic agent.,
| Conclusion|| |
Our findings demonstrated that administration of EEBS mediated its effect through multiple pathways including significant antioxidant activity, diuretic activity along with normalization of urine pH, protective effect against drug-induced proteinuria, hypercalciuria, hypercalcemia, and hyperphosphatemia. EEBS also restored the elevated serum level of BUN, uric acid, and creatinine and diminished total protein level. Improvement in the body weight of animals and lowering of kidney weight were also observed. Hypermagnesuric effect observed in the EG + EEBS-treated animals, clearly indicating its antiurolithic activity. Hence, our findings provide necessary evidence for the ethnomedicinal usage of this plant as nephroprotective and antiurolithic agent. Antiurolithic activity may be attributed mainly due to the presence of saponins, as it possesses anticrystallization properties. Significant antioxidant property of EEBS is due to the presence of bioactive phytoconstituents such as amentoflavone, a bioflavonoid with trace amounts of cupressoflavone, luteolin, isoorientin, and isovitexin. Hence, supplementation of EEBS along with drugs inducing urolithiasis may exhibit excellent antiurolithic and antioxidant activity.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Deorao MA, Vaishali M, Santi PB, Shardha PC. Antilithiatic effect of Achyranthus aspera
Linn. leaves extract on ethylene glycol induced nephrolithiasis. J Pharm Res 2009;2:994-7.
Hamid M, Mohammad MN, Ghanea L. Evaluation of the Raphanus sativus
effect on urinary pH. J Res Med Sci 2007;12:58-61.
Moe OW, Pearle MS, Sakhaee K. Pharmacotherapy of urolithiasis: Evidence from clinical trials. Kidney Int 2011;79:385-92.
Pak CY. Prevention and treatment of kidney stones. Role of medical prevention. J Urol 1989;141:798-801.
Kmiecik J, Kucharska E, Sułowicz W, Ochmański W. Etiology and pathogenesis of urolithiasis. Przegl Lek 1997;54:173-9.
Thamilselvan S, Hackett RL, Khan SR. Lipid peroxidation in ethylene glycol induced hyperoxaluria and calcium oxalate nephrolithiasis. J Urol 1997;157:1059-63.
Huang HS, Ma MC, Chen CF, Chen J. Lipid peroxidation and its correlations with urinary levels of oxalate, citric acid, and osteopontin in patients with renal calcium oxalate stones. Urology 2003;62:1123-8.
Muthusamy VV, Muthu P. Usefulness of history-taking, physical examination and diagnostic scoring in acute renal colic. Prove 1980;19:130-1.
Editorial Committee of the Flora of Taiwan. Flora of Taiwan. 2nd
ed., Vol. 3. Taipei: Epoch Publication; 1993.
Yun-Lian L, Wan-Yi W. Chemical constituents of Biophytum sensitivum
. Chin Pharm J 2003;55:71-5.
Bucar F, Jachak SM, Schubert ZM, Kartnig T. Phenolic compounds from Biophytum sensitivum
. Pharmazie 1998;153:651-3.
Sala AV. Indian Medicinal Plants. Vol. 1. Chennai: Orient Longman Limited; 2002. p. 271.
Guruvayoorappan C, Afira AH, Kuttan G. Antioxidant potential of Biophytum sensitivum
extract in vitro
and in vivo
. J Basic Clin Physiol Pharmacol 2006;17:255-67.
Natarajan D, Shivakumar MS, Srinivasan R. Antibacterial activity of leaf extracts of Biophytum sensitivum
(L.) DC. J Pharm Sci Res 2010;2:717-20.
Puri D. Screening of mildly hypoglycaemic compounds: Obese British Angora rabbits with borderline glucose intolerance as animal model. Indian J Pharm Sci 2006;68:579-83. [Full text]
Guruvayoorappan C, Kuttan G. Amentoflavone inhibits experimental tumor metastasis through a regulatory mechanism involving MMP-2, MMP-9, prolyl hydroxylase, lysyl oxidase, VEGF, ERK-1, ERK-2, STAT-1, NM23 and cytokines in lung tissues of C57BL/6 mice. Immunopharmacol Immunotoxicol 2008;30:711-27.
Guruvayoorappan C, Kuttan G. Anti-metastatic effect of Biophytum sensitivum
is exerted through its cytokine and immunomodulatory activity and its regulatory effect on the activation and nuclear translocation of transcription factors in B16F-10 melanoma cells. J Exp Ther Oncol 2008;7:49-63.
Puri D. Hypocholesterolemic effect of Biophytum sensitivum
leaf water extract. Pharm Biol 2003;41:253-8.
Jachak SM, Bucar F, Kartnig T. Antiinflammatory activity of extracts of Biophytum sensitivum
in carrageenin-induced rat paw oedema. Phytother Res 1999;13:73-4.
Soundararajan P, Mahesh R, Ramesh T, Hazeena BV. Biopotency of Aerva lanata
on membrane bound ATPases and marker enzymes in urolithiatic rats. IRJP 2007;1:221-8.
Pareta SK, Kartik CP, Papiya MM, Dinakar S. Boerhaavia diffusa
Linn aqueous extract as curative agent in ethylene glycol induced urolithiasis. Pharmacologyonline 2010;3:112-20.
Atmani F, Slimani Y, Mimouni M, Hacht B. Prophylaxis of calcium oxalate stones by Herniaria hirsuta
on experimentally induced nephrolithiasis in rats. BJU Int 2003;92:137-40.
Cooper JW, Gunn C. Tutorial pharmacy. In: Infusion and Maceration Processes. 5th
ed. London: Pitman Medical; 1957. p. 308-17.
Kirtikar KR, Basu BD. Indian Medicinal Plants. Vol. 1. Dehradun: International Book Distributors; 1998. p. 1045-8.
Anindya B, Md Harun AR, Abdur R, Tapas KP. In vivo
screening of ethanolic extract of Biophytum sensitivum
DC leaves on peptic ulcer induced by aspirin in Wistar Albino rats. Int J Pharm Phytopharmacol Res 2014;3:418-22.
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951;193:265-75.
Lorentz K. Improved determination of serum calcium with 2-cresolphthalein complexone. Clin Chim Acta 1982;126:327-34.
Fiske CH, Subbarow Y. The colorimetric determination of phosphorus. J Biol Chem 1925;66:375-81.
Heaton FW. Determination of magnesium by the titan yellow and ammonium phosphate methods. J Clin Pathol 1960;13:358-60.
Fawcett JK, Scott JE. A rapid and precise method for the determination of urea. J Clin Pathol 1960;13:156-9.
Caraway WT. Uric acid. In: Seligson D, editor. Standard Methods of Clinical Chemistry. London: Academic Press; 1963. p. 239-47.
Bonsnes RW, Tauss HH. On the colourimetric determination of creatinine by Jaffe reaction. J Biol Chem 1945;158:581-91.
Kakkar PD, Viswanathan PN. A modified spectrophotometric assay of SOD. Indian J Biochem Biophy 1984;21:130-2.
Sinha AK. Colorimetric assay of catalase. Anal Biochem 1972;47:389-94.
Ahrens RA. Glutathione peroxidase: A role for selenium (Rotruck 1972). J Nutr 1997;127:1052S-3S.
Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys 1959;82:70-7.
Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979;95:351-8.
Drury RE, Walligton E. Histological Techniques. 5th
ed. New York, Pronto: Carlton, Oxford University Press; 1980. p. 206.
Khan SR. Animal models of kidney stone formation: An analysis. World J Urol 1997;15:236-43.
Selvam R, Kalaiselvi P, Govindaraj A, Bala Murugan V, Sathish Kumar AS. Effect of A. lanata
leaf extract and Vediuppu Chunnam
on the urinary risk factors of calcium oxalate urolithiasis during experimental hyperoxaluria. Pharmacol Res 2001;43:89-93.
Brent J. Current management of ethylene glycol poisoning. Drugs 2001;61:979-88.
Morley JE, Levine AS, Rowland NE. Minireview. Stress induced eating. Life Sci 1983;32:2169-82.
Hiremath RD, Jalalpure SS. Effect of hydro-alcoholic extract of Vernonia cinerea
less. Against ethylene glycol-induced urolithiasis in rats. Indian J Pharmacol 2016;48:434-40.
] [Full text]
Moe OW, Abate N, Sakhaee K. Pathophysiology of uric acid nephrolithiasis. Endocrinol Metab Clin North Am 2002;31:895-914.
Ebrahimpour A, Perez L, Nancollas GH. Induced crystal growth of calcium oxalate monohydrate at hydroxyapatite surfaces. The influence of human serum albumin, citrate, and magnesium. Langmuir 1991;7:577-83.
Farooq SM, Ebrahim AS, Subramhanya KH, Sakthivel R, Rajesh NG, Varalakshmi P, et al.
Oxalate mediated nephronal impairment and its inhibition by c-phycocyanin: A study on urolithic rats. Mol Cell Biochem 2006;284:95-101.
Roger K, Low MD, Stoller ML. Uric acid nephrolithiasis. Urol Clin North Am 1997;24:135-48.
Grases F, Genestar C, Conte A, March P, Costa-Bauzá A. Inhibitory effect of pyrophosphate, citrate, magnesium and chondroitin sulphate in calcium oxalate urolithiasis. Br J Urol 1989;64:235-7.
Ghodkar PB. Chemical tests in kidney disease. Text Book of Medical Laboratory Technology. Mumbai: Bhalani Publishing House; 1994. p. 18-32.
Blokhina O, Virolainen E, Fagerstedt KV. Antioxidants, oxidative damage and oxygen deprivation stress: A review. Ann Bot 2003;91:179-94.
Punitha IS, Rajendran K, Shirwaikar A, Shirwaikar A. Alcoholic stem extract of Coscinium fenestratum
regulates carbohydrate metabolism and improves antioxidant status in streptozotocin-nicotinamide induced diabetic rats. Evid Based Complement Alternat Med 2005;2:375-81.
Kurien TB, Selvam R. Induction of lipid peroxidation in calcium oxalate stone formation. Indian J Exp Biol 1989;27:450-3.
Shah JG, Patel BG, Patel SB, Patel RK. Antiurolithiatic and antioxidant activity of Hordeum vulgare
seeds on ethylene glycol-induced urolithiasis in rats. Indian J Pharmacol 2012;44:672-7.
] [Full text]
Ashok P, Koti BC, Vishwanathswamy AH. Antiurolithiatic and antioxidant activity of Mimusops elengi
on ethylene glycol-induced urolithiasis in rats. Indian J Pharmacol 2010;42:380-3.
] [Full text]
Gürocak S, Küpeli B. Consumption of historical and current phytotherapeutic agents for urolithiasis: A critical review. J Urol 2006;176:450-5.
[Table 1], [Table 2], [Table 3]